Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial
暂无分享，去创建一个
Amber C. Donahue | X. Mu | R. Motzer | T. Powles | T. Choueiri | J. Haanen | G. Gravis | B. Alekseev | M. Uemura | S. Pal | M. Campbell | J. Larkin | L. Albiges | P. Robbins | S. Hariharan | A. di Pietro | J. Lee | Jing Wang | Weidong Zhang | K. Ching | K. Penkov | A. Chudnovsky | Xiao Wang